Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		144,806,464
Beginning balance at Dec. 31, 2023	$ 1,155,610	$ 15	$ 2,295,807	$ (1,375)	$ (1,138,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		471,310
Exercise of stock options	7,140		7,140
Stock-based compensation	42,590		42,590
Issuance of common stock upon settlement of restricted stock units (in shares)		994,029
Other comprehensive income (loss)	(693)			(693)
Net loss	(10,966)				(10,966)
Ending balance (in shares) at Mar. 31, 2024		146,271,803
Ending balance at Mar. 31, 2024	1,193,681	$ 15	2,345,537	(2,068)	(1,149,803)
Beginning balance (in shares) at Dec. 31, 2024		149,853,135
Beginning balance at Dec. 31, 2024	$ 1,288,353	$ 15	2,535,868	(2,737)	(1,244,793)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	149,650	149,650
Exercise of stock options	$ 2,352		2,352
Stock-based compensation	52,402		52,402
Issuance of common stock upon settlement of restricted stock units (in shares)		882,979
Issuance of common stock upon settlement of restricted stock units	0
Shares withheld related to net share settlement of equity awards (in shares)		(331,056)
Shares withheld related to net share settlement of equity awards	(28,277)		(28,277)
Repurchase and retirement of common stock, including transaction costs and excise tax (in shares)		(1,450,591)
Repurchase and retirement of common stock, including transaction costs and excise tax	(100,440)		(100,440)
Other comprehensive income (loss)	246			246
Net loss	(32,989)				(32,989)
Ending balance (in shares) at Mar. 31, 2025		149,104,117
Ending balance at Mar. 31, 2025	$ 1,181,647	$ 15	$ 2,461,905	$ (2,491)	$ (1,277,782)